In-vitro Colorectal Cancer Screening Tests Market Report

Europe In-vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 15, 2019
  • PAGES：216
  • REPORT CODE：GMM321794
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The In-vitro Colorectal Cancer Screening Tests market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe In-vitro Colorectal Cancer Screening Tests Market Segmentations:

    By Player:

    • BioTime, Inc

    • Eiken Chemical.

    • Randox Laboratories

    • Alere, Inc

    • Merck Millipore

    • Epigenomics AG

    • Mode Diagnostics

    • Sysmex Corporation

    • Quest Diagnostics

    • Abbott Molecular, Inc

    • Oncocyte

    • Beckman Coulter, Inc

    • R-Biopharm

    • Exact Sciences Corporation.

    • Immunostics

    • Siemens Healthcare.

    • Companion Dx

    • ExiQon, Kyowa Medex.

    • CML Healthcare, Inc

    • Novigenix SA.

    By Type:

    • Fecal Occult Blood Tests

    • Stool Biomarkers Tests

    • Blood Biomarkers Tests

    By End-User:

    • MarCarePlex

    • Cologic

    • Colox

    • miRSIGN

    • PanC - Dx

    • MeScore CRC

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of In-vitro Colorectal Cancer Screening Tests Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Fecal Occult Blood Tests from 2014 to 2026

    • 1.3.2 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Stool Biomarkers Tests from 2014 to 2026

    • 1.3.3 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Blood Biomarkers Tests from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of MarCarePlex from 2014 to 2026

    • 1.4.2 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Cologic from 2014 to 2026

    • 1.4.3 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Colox from 2014 to 2026

    • 1.4.4 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of miRSIGN from 2014 to 2026

    • 1.4.5 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of PanC - Dx from 2014 to 2026

    • 1.4.6 Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of MeScore CRC from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of In-vitro Colorectal Cancer Screening Tests Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of In-vitro Colorectal Cancer Screening Tests by Major Types

      • 3.4.1 Market Size and Growth Rate of Fecal Occult Blood Tests

      • 3.4.2 Market Size and Growth Rate of Stool Biomarkers Tests

      • 3.4.3 Market Size and Growth Rate of Blood Biomarkers Tests

    4 Segmentation of In-vitro Colorectal Cancer Screening Tests Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of In-vitro Colorectal Cancer Screening Tests by Major End-Users

      • 4.4.1 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for MarCarePlex

      • 4.4.2 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for Cologic

      • 4.4.3 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for Colox

      • 4.4.4 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for miRSIGN

      • 4.4.5 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for PanC - Dx

      • 4.4.6 Market Size and Growth Rate of In-vitro Colorectal Cancer Screening Tests for MeScore CRC

    5 Market Analysis by Major Regions

    • 5.1 Europe In-vitro Colorectal Cancer Screening Tests Production Analysis by Top Regions

    • 5.2 Europe In-vitro Colorectal Cancer Screening Tests Consumption Analysis by Top Regions

    • 5.3 Europe In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.2 UK In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.3 France In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    6 Product Circulation of In-vitro Colorectal Cancer Screening Tests Market among Top Countries

    • 6.1 Top 5 Export Countries in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 7.1 Germany In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 7.2 Germany In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    8. UK In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 8.1 UK In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 8.2 UK In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    9. France In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 9.1 France In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 9.2 France In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    10. Italy In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 10.1 Italy In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 10.2 Italy In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    11. Spain In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 11.1 Spain In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 11.2 Spain In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    12. Poland In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 12.1 Poland In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 12.2 Poland In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    13. Russia In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 13.1 Russia In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 13.2 Russia In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    14. Switzerland In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 14.1 Switzerland In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 14.2 Switzerland In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    15. Turkey In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 15.1 Turkey In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 15.2 Turkey In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Top Countries

      • 16.3.1 Denmark In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 16.3.2 Finland In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 16.3.3 Norway In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 16.3.4 Sweden In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 16.3.6 Iceland In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Top Countries

      • 17.3.1 Belgium In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 17.3.2 Netherlands In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 17.3.3 Luxembourg In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Landscape Analysis by Top Countries

      • 18.3.1 Estonia In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 18.3.2 Latvia In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

      • 18.3.3 Lithuania In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 BioTime, Inc

      • 19.1.1 BioTime, Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Eiken Chemical.

      • 19.2.1 Eiken Chemical. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Randox Laboratories

      • 19.3.1 Randox Laboratories Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Alere, Inc

      • 19.4.1 Alere, Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck Millipore

      • 19.5.1 Merck Millipore Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Epigenomics AG

      • 19.6.1 Epigenomics AG Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mode Diagnostics

      • 19.7.1 Mode Diagnostics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Sysmex Corporation

      • 19.8.1 Sysmex Corporation Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Quest Diagnostics

      • 19.9.1 Quest Diagnostics Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Abbott Molecular, Inc

      • 19.10.1 Abbott Molecular, Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Oncocyte

      • 19.11.1 Oncocyte Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Beckman Coulter, Inc

      • 19.12.1 Beckman Coulter, Inc Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 R-Biopharm

      • 19.13.1 R-Biopharm Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Exact Sciences Corporation.

      • 19.14.1 Exact Sciences Corporation. Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Immunostics

      • 19.15.1 Immunostics Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Siemens Healthcare.

      • 19.16.1 Siemens Healthcare. Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Companion Dx

      • 19.17.1 Companion Dx Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 ExiQon, Kyowa Medex.

      • 19.18.1 ExiQon, Kyowa Medex. Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 CML Healthcare, Inc

      • 19.19.1 CML Healthcare, Inc Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Novigenix SA.

      • 19.20.1 Novigenix SA. Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 100 Figures and 143 Tables)

    • Figure Product Picture

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Fecal Occult Blood Tests from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Stool Biomarkers Tests from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Blood Biomarkers Tests from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of MarCarePlex from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Cologic from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of Colox from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of miRSIGN from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of PanC - Dx from 2014 to 2026

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate of MeScore CRC from 2014 to 2026

    • Figure Germany In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure UK In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure France In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Italy In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Spain In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Poland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Russia In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Canada In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Finland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Norway In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania In-vitro Colorectal Cancer Screening Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of In-vitro Colorectal Cancer Screening Tests Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of In-vitro Colorectal Cancer Screening Tests

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of In-vitro Colorectal Cancer Screening Tests by Different Types from 2014 to 2026

    • Table Consumption Share of In-vitro Colorectal Cancer Screening Tests by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fecal Occult Blood Tests

    • Figure Market Size and Growth Rate of Stool Biomarkers Tests

    • Figure Market Size and Growth Rate of Blood Biomarkers Tests

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of In-vitro Colorectal Cancer Screening Tests by Different End-Users from 2014 to 2026

    • Table Consumption Share of In-vitro Colorectal Cancer Screening Tests by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of MarCarePlex

    • Figure Market Size and Growth Rate of Cologic

    • Figure Market Size and Growth Rate of Colox

    • Figure Market Size and Growth Rate of miRSIGN

    • Figure Market Size and Growth Rate of PanC - Dx

    • Figure Market Size and Growth Rate of MeScore CRC

    • Table Europe In-vitro Colorectal Cancer Screening Tests Production by Major Regions

    • Table Europe In-vitro Colorectal Cancer Screening Tests Production Share by Major Regions

    • Figure Europe In-vitro Colorectal Cancer Screening Tests Production Share by Major Countries and Regions in 2014

    • Table Europe In-vitro Colorectal Cancer Screening Tests Consumption by Major Regions

    • Table Europe In-vitro Colorectal Cancer Screening Tests Consumption Share by Major Regions

    • Table Germany In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table UK In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table France In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Italy In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Spain In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Poland In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Russia In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Switzerland In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Turkey In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in In-vitro Colorectal Cancer Screening Tests Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Germany In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Germany In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Germany In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table UK In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table UK In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table UK In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table UK In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table France In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table France In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table France In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table France In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Italy In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Italy In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Italy In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Italy In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Spain In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Spain In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Spain In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Spain In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Poland In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Poland In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Poland In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Poland In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Russia In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Russia In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Russia In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Russia In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Switzerland In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Switzerland In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Switzerland In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Turkey In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Turkey In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Turkey In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Turkey In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) In-vitro Colorectal Cancer Screening Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) In-vitro Colorectal Cancer Screening Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) In-vitro Colorectal Cancer Screening Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries In-vitro Colorectal Cancer Screening Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of BioTime, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTime, Inc

    • Figure Sales and Growth Rate Analysis of BioTime, Inc

    • Figure Revenue and Market Share Analysis of BioTime, Inc

    • Table Product and Service Introduction of BioTime, Inc

    • Table Company Profile and Development Status of Eiken Chemical.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eiken Chemical.

    • Figure Sales and Growth Rate Analysis of Eiken Chemical.

    • Figure Revenue and Market Share Analysis of Eiken Chemical.

    • Table Product and Service Introduction of Eiken Chemical.

    • Table Company Profile and Development Status of Randox Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Randox Laboratories

    • Figure Sales and Growth Rate Analysis of Randox Laboratories

    • Figure Revenue and Market Share Analysis of Randox Laboratories

    • Table Product and Service Introduction of Randox Laboratories

    • Table Company Profile and Development Status of Alere, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere, Inc

    • Figure Sales and Growth Rate Analysis of Alere, Inc

    • Figure Revenue and Market Share Analysis of Alere, Inc

    • Table Product and Service Introduction of Alere, Inc

    • Table Company Profile and Development Status of Merck Millipore

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Millipore

    • Figure Sales and Growth Rate Analysis of Merck Millipore

    • Figure Revenue and Market Share Analysis of Merck Millipore

    • Table Product and Service Introduction of Merck Millipore

    • Table Company Profile and Development Status of Epigenomics AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics AG

    • Figure Sales and Growth Rate Analysis of Epigenomics AG

    • Figure Revenue and Market Share Analysis of Epigenomics AG

    • Table Product and Service Introduction of Epigenomics AG

    • Table Company Profile and Development Status of Mode Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mode Diagnostics

    • Figure Sales and Growth Rate Analysis of Mode Diagnostics

    • Figure Revenue and Market Share Analysis of Mode Diagnostics

    • Table Product and Service Introduction of Mode Diagnostics

    • Table Company Profile and Development Status of Sysmex Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sysmex Corporation

    • Figure Sales and Growth Rate Analysis of Sysmex Corporation

    • Figure Revenue and Market Share Analysis of Sysmex Corporation

    • Table Product and Service Introduction of Sysmex Corporation

    • Table Company Profile and Development Status of Quest Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics

    • Figure Revenue and Market Share Analysis of Quest Diagnostics

    • Table Product and Service Introduction of Quest Diagnostics

    • Table Company Profile and Development Status of Abbott Molecular, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Molecular, Inc

    • Figure Sales and Growth Rate Analysis of Abbott Molecular, Inc

    • Figure Revenue and Market Share Analysis of Abbott Molecular, Inc

    • Table Product and Service Introduction of Abbott Molecular, Inc

    • Table Company Profile and Development Status of Oncocyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncocyte

    • Figure Sales and Growth Rate Analysis of Oncocyte

    • Figure Revenue and Market Share Analysis of Oncocyte

    • Table Product and Service Introduction of Oncocyte

    • Table Company Profile and Development Status of Beckman Coulter, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter, Inc

    • Figure Sales and Growth Rate Analysis of Beckman Coulter, Inc

    • Figure Revenue and Market Share Analysis of Beckman Coulter, Inc

    • Table Product and Service Introduction of Beckman Coulter, Inc

    • Table Company Profile and Development Status of R-Biopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of R-Biopharm

    • Figure Sales and Growth Rate Analysis of R-Biopharm

    • Figure Revenue and Market Share Analysis of R-Biopharm

    • Table Product and Service Introduction of R-Biopharm

    • Table Company Profile and Development Status of Exact Sciences Corporation.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exact Sciences Corporation.

    • Figure Sales and Growth Rate Analysis of Exact Sciences Corporation.

    • Figure Revenue and Market Share Analysis of Exact Sciences Corporation.

    • Table Product and Service Introduction of Exact Sciences Corporation.

    • Table Company Profile and Development Status of Immunostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunostics

    • Figure Sales and Growth Rate Analysis of Immunostics

    • Figure Revenue and Market Share Analysis of Immunostics

    • Table Product and Service Introduction of Immunostics

    • Table Company Profile and Development Status of Siemens Healthcare.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare.

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare.

    • Figure Revenue and Market Share Analysis of Siemens Healthcare.

    • Table Product and Service Introduction of Siemens Healthcare.

    • Table Company Profile and Development Status of Companion Dx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Companion Dx

    • Figure Sales and Growth Rate Analysis of Companion Dx

    • Figure Revenue and Market Share Analysis of Companion Dx

    • Table Product and Service Introduction of Companion Dx

    • Table Company Profile and Development Status of ExiQon, Kyowa Medex.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ExiQon, Kyowa Medex.

    • Figure Sales and Growth Rate Analysis of ExiQon, Kyowa Medex.

    • Figure Revenue and Market Share Analysis of ExiQon, Kyowa Medex.

    • Table Product and Service Introduction of ExiQon, Kyowa Medex.

    • Table Company Profile and Development Status of CML Healthcare, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CML Healthcare, Inc

    • Figure Sales and Growth Rate Analysis of CML Healthcare, Inc

    • Figure Revenue and Market Share Analysis of CML Healthcare, Inc

    • Table Product and Service Introduction of CML Healthcare, Inc

    • Table Company Profile and Development Status of Novigenix SA.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novigenix SA.

    • Figure Sales and Growth Rate Analysis of Novigenix SA.

    • Figure Revenue and Market Share Analysis of Novigenix SA.

    • Table Product and Service Introduction of Novigenix SA.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US